CoChat

An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments

Tomitsuka, Eriko, Kita, Kiyoshi, Esumi, Hiroyasu · 2012 · The Journal of Biochemistry

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Increased glycolysis is the principal explanation for how cancer cells generate energy in the absence of oxygen. However, in actual human tumour microenvironments, hypoxia is often associated with hypoglycemia because of the poor blood supply. Therefore, glycolysis cannot be the sole mechanism for the maintenance of the energy status in cancers. To understand energy metabolism in cancer cells under hypoxia-hypoglycemic conditions mimicking the tumour microenvironments, we examined the NADH-fumarate reductase (NADH-FR) system, which functions in parasites under hypoxic condition, as a candidate mechanism. In human cancer cells (DLD-1, Panc-1 and HepG2) cultured under hypoxic-hypoglycemic conditions, NADH-FR activity, which is composed of the activities of complex I (NADH-ubiquinone reductase) and the reverse reaction of complex II (quinol-FR), increased, whereas NADH-oxidase activity decreased. Pyrvinium pamoate (PP), which is an anthelmintic and has an anti-cancer effect within tumour-mimicking microenvironments, inhibited NADH-FR activities in both parasites and mammalian mitochondria. Moreover, PP increased the activity of complex II (succinate-ubiquinone reductase) in mitochondria from human cancer cells cultured under normoxia-normoglycemic conditions but not under hypoxia-hypoglycemic conditions. These results indicate that the NADH-FR system may be important for maintaining mitochondrial energy production in tumour microenvironments and suggest its potential use as a no…

Overview

Integrity signals

Registry

Crossref · 10.1093/jb/mvs041

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 83

Metadata

Authors
Tomitsuka, E., Kita, K., & Esumi, H.
Affiliations
National Cancer Centre Japan (JP)
Corresponding author
Tomitsuka, Eriko
Venue
The Journal of Biochemistry
Published
2012-04-23
Volume
152
Issue
2
Pages
171-183
ISSN
  • 0021-924X (ISSN-L)
  • 1756-2651
OpenAlex
W2142261125
Cited by
79
References
50
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 12 · 2012: 1
FWCI
2.54
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Hirosaki University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
pyrvinium pamoate, mitochondrial bioenergetics, tumor microenvironment, hypoxia, hypoglycemia, cancer cell energy metabolism, NADH-ubiquinone reductase, succinate-ubiquinone reductase, NADH oxidase, therapeutic target
MeSH terms
Animals, Hypoxia, Anthelmintics, Antineoplastic Agents, Cattle, Energy Metabolism, Enzyme Inhibitors, Humans, Hypoglycemia, Mitochondria, Mitochondria, Heart, Pyrvinium Compounds, Tumor Cells, Cultured, Cell Hypoxia, Ascaris suum, Electron Transport Complex II, Oxidoreductases Acting on CH-CH Group Donors, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.